Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 0/I Dose Escalation Study of Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma

NCT04477200 is registered in ClinicalTrials.gov with University of Michigan Rogel Cancer Center as lead sponsor.

NCT NCT04477200
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04477200 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 0/I Dose Escalation Study of Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma
Lead sponsor
University of Michigan Rogel Cancer Center
Phase
Phase 1
Overall status
Active, not recruiting
Start date
August 5, 2020
Completion date
November 5, 2027
Enrollment
68 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

newly diagnosed astrocytoma, grade iv, newly diagnosed glioblastoma, newly diagnosed gliosarcoma, recurrent astrocytoma, grade iv, recurrent glioblastoma, recurrent gliosarcoma